Anthracycline cardiotoxicity: one size does not fit all!
Hershman
Dawn L
DL
Neugut
Alfred I
AI
D018943:Anthracyclines / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D006278:Medicare; D011237:Predictive Value of Tests; D011788:Quality of Life; D012307:Risk Factors; D018426:SEER Program; D014481:United States
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D015251:Epirubicin